GABRIEL GARCIA, M - Stanford University

GABRIEL GARCIA, M.D.

CURRICULUM VITAE

ADDRESS Professor of Medicine (Gastroenterology)

Liver Transplant Program 750 Welch Road, Suite 210

Palo Alto, CA 94304 Tell: (650) 725-3360

Fax: (650) 498-5692 E-mail: [email protected] ALTERNATE ADDRESS Associate Dean for Medical School Admissions Stanford University School of Medicine 251 Campus Drive West, MSOB X335 Stanford, California 94305-5404 Tel: (650) 725-3948 Fax: (650) 725-7855 E-mail: [email protected] DATE OF BIRTH April 29, 1952 BIRTHPLACE Havana, Cuba MARITAL STATUS Married, 1 daughter MEDICAL LICENSE California, G38402 EDUCATION 1973 Cornell University, Ithaca, New York, A.B. 1977 New York University, New York, New York, M.D. POST-GRADUATE TRAINING 1977-1981 Intern, Medical Resident and Chief Medical Resident

Stanford University School of Medicine, Stanford, California 1981-1984 Fellow in Gastroenterology

Stanford University School of Medicine, Stanford, California 1982-1987 Fellow in Substance Abuse and Alcoholism,

Veterans Administration Medical Center, Palo Alto, California 1984-1987 Research Fellow in Infectious Diseases,

Stanford University School of Medicine, Stanford, California

mailto:[email protected]

mailto:[email protected]

Gabriel Garcia, M.D.

BOARD OF CERTIFICATION 1978 Diplomate, National Board of Medical Examiners 1981 Diplomate, American Board of Internal Medicine 1985 Diplomate, American Board of Internal Medicine

Subspecialty of Gastroenterology

EMPLOYMENT 1974-1975 Instructor in Medical Spanish

New York University Medical Center, New York, New York 1980-1981 Acting Instructor, Department of Medicine

Stanford University School of Medicine, Stanford, California

1980-1982 Acting Instructor, Department of Surgery (Emergency Medicine) Stanford University School of Medicine, Stanford, California 1984-1987 Clinical Instructor/VCF, Department of Medicine (Gastroenterology)

Stanford University School of Medicine, Stanford, California 1987-1989 Assistant Professor of Medicine (Gastroenterology)

Baylor College of Medicine, Houston, Texas 1989-1993 Assistant Professor of Medicine (Gastroenterology)

Stanford University School of Medicine 1989-1995 Chief, Clinical Gastroenterology

Stanford University School of Medicine, Stanford, California 1991-present Transplant Physician, Liver Transplant Unit,

Stanford University School Medicine, Stanford, California 1993-2005 Associate Professor of Medicine (Gastroenterology)

Stanford University School of Medicine, Stanford, California 1998-present Director, Committee of Admissions,

Stanford University School of Medicine, Stanford, California 1998-present Associate Dean of Medical School Admissions,

Stanford University, Stanford, California

2005-present Professor of Medicine (Gastroenterology) Stanford University School of Medicine, Stanford, California 2006- present Peter E. Haas Director, Haas Center for Public Service at Stanford University

2


HONORS 1970 Presidential Scholar, Commonwealth of Puerto Rico 1972 J.G. White Prize for Excellence in Literature, Cornell University 1977 Alpha Omega Alpha, New York University 1980 Chief Medical Resident, Department of Medicine

Stanford University School of Medicine

1989 Fellow, American College of Gastroenterology 1990 Finalist, Henry J. Kaiser Teaching Award, Stanford University 1991 Finalist, Henry J. Kaiser Teaching Award, Stanford University 1991 Fellow, American College of Physicians 1990 Nominee, Alwin C. Rambar for Excellence in Patient Care 1999 Recipient, Governor’s Award for Excellence in Research,

American College of Gastroenterology

GRANT SUPPORT 1984-1985 National Research Services Award, National Institutes of Health, “State of Viral

DNA in chronic hepatitis B and non-A, non-B,” 2 T32 AI 07089-06 1985-1989 Physician Scientist Award, National Institutes of Health, “Expression of HbsAg

in attenuated pathogens” 1K11 AI00634 1991-1993 HEM Pharmaceuticals, “A multicenter phase I/II study of the activity and safety

of Ampligen in patients with chronic hepatitis B infection,” 1992-1995 Burroughs Wellcome Company, “A randomized trial to compare the efficacy and

safety of Wellferon and Intron A for the treatment of chronic hepatitis C” 1993-2002 Technical Training Foundation, Studies in Hepatitis C 1994-1995 Viagene, Inc. “Monitoring cytotoxic T cell responses in patients with acute and

chronic hepatitis B” 1996-1998 Roche Molecular Systems, Inc., “Treatment of chronic hepatitis C: stratification

by pre-treatment viral burden”

3


1996-1998 SmithKline Beecham Pharmaceuticals, “a double-blinded, parallel group,

placebo controlled, multicenter, phase IIIA study to assess the safety and efficacy of oral famciclovir (three times a day and once a day) treatment of chronic hepatitis B”

1997-1998 Schering-Plough Corporation, “Dose escalation of oral ribavirin/placebo +

interferon for the treatment of chronic hepatitis C in interferon naïve patients,” co-investigator

1997-1998 Schering Plough Corporation, “Dose escalation of oral ribavirin/placebo +

interferon for the treatment of chronic hepatitis C in patients who failed a previous course of interferon,” co-investigator

1998-1999 American College of Gastroenterology, “Outcome in Chronic Hepatitis B”

1998-1999 NIH Pilot Study, “Quality of Life in Chronic Viral hepatitis,” 1998-2000 Co-Investigator: Randomized, nonblinded, multicenter, parallel-group trial to

compare the efficacy of 9 μg interferon alfacon-1 administered subcutaneously three times per week for 48 or 72 weeks or once daily for 48 weeks in patients with chronic hepatitis C virus (HCV) infection previously untreated with interferon. Amgen

1998-1999 Co-Investigator: Transfusion of photochemically treated S-59 reduced, fresh

frozen plasma in patients with multiple coagulation factor deficiencies. Cerus Corporation

1998-present Co-Investigator-SUMC: Chronic HBV and HCV infection and other liver

diseases: pathogenesis, natural history, and new approaches to diagnosis and treatment. Hutchison Grant

1998-1999 Co-Investigator A phase I, open-label, dose escalation study of the safety and

antiviral effects of intravenous administration of two human HBV-antibodies (HBV-AbXTL17.1.41 and HBV-AbXTL19.79.5) to subjects with chronic hepatitis B. XTL Biopharmaceuticals Ltd

1999-2000 Co-Investigator: Efficacy of Infergen for chronic hepatitis C in patients who are

non-responders and relapsers to combination therapy with Intron-A + ribavirin. A multi-center trial. Amgen

1999-2000 Co-Investigator: Multicenter randomized trial of 15 mcg Infergen (interferon

alfacon-1) administered daily vs. thrice weekly in patients with chronic hepatitis C who did not respond to interferon therapy. Amgen

. 1999-2001 Co-Investigator: A randomized, open-label, multicenter, efficacy, tolerability and

safety study of Pegasys™ vs. Rebetron™ in interferon and ribavirin treatment-naïve patients with chronic hepatitis C virus infection. Roche Laboratories

4


1999-2001 Co-Investigator: A randomized, open-label, multicenter, efficacy and safety study of Pegysys™ plus ribavirin, Pegasys™ plus CellCept, Pegasys™ plus amantadine, and Pegasys™ plus amantadine plus ribavirin in patients with chronic HCV infection who have previously not responded to at least 12 weeks of treatment with Rebetron™. Roche Laboratories

2000-2001 Co-Investigator: A phase I, open-label, study of the safety and anti-viral effects

of ascending multiple intravenous doses of two human HBV-antibodies (HBV-AbXTL17.1.41 and HBV-AbXTL19.79.5) in patients with chronic hepatitis B infection. XTL Biopharmaceuticals Ltd

2000 Co-Investigator:Variability of serum HCV RNA levels in patients with

compensated chronic HCV infection. Eli Lilly

2000-2002 Co-Investigator: Long-term PEG Intron vs colchicine for patients who have failed to respond to Rebetron/interferon with advanced fibrosis and cirrhosis secondary to hepatitis C. Schering

2001-2002 Co-Investigator: Multinational, multicenter, double blind, placebo controlled,

randomized, parallel groups study of rifaximin clinical effectiveness and tolerability in patients suffering from hepatic encephalopathy and who are intolerant to lactulose or lactitol. Salix Pharmaceuticals

2001-2004 Co-Investogator and Principle Investigator: University of California Task Force

for Diversity in Medical Education, California Endowment 2002-2004 Co-Investigator: A prospective, randomized, multicenter, open-label,

comparative safety study of Pegasys vs Pegasys plus ribavirin treatment vs a twelve-week treatment delay in patients with chronic hepatitis C. Roche

2002-2003 Co-Investigator A Phase III Study Of The Safety And Antiviral Activity Of

Entecavir Vs Lamivudine In Adults With Chronic Hepatitis B Infection Who Are Positive For Hepatitis B E Antigen. Bristol Myers Squibb

2002-2003 Co-Investigator A Phase III Study Of The Safety And Antiviral Activity Of

Entecavir Vs Lamivudine In Adults With Chronic Hepatitis B Infection Who Are Negative For Hepatitis B E Antigen. Bristol Myers Squibb

2000-2003 Roche Pharmaceuticals, A Multicenter, Open-Label Study Investigating the

Efficacy of Pegasys in Combination with Ribavirin as Initial Treatment of Chronic Hepatitis C in Non Hispanic African-American HCV Genotype 1 Patients as Compared to Non-Hispanic Caucasian HCV Genotype 1 Patients

2003-2004 “Utilization of Healthcare Services by Stanford Students from Low-Income

Families,” supervising Anna Chen, a Stanford undergraduate, funded by UROG 2003-2004 “Sleep Disturbance in Cirrhotic Patients,” supervising Jose Miguel Iturbe, a

Stanford undergraduate, funded by Presidential Scholar Grant

5


2003-2004 “Use of Allopathic versus Traditional Medical Care in Chinese Immigrants,” supervising Amanda Schwartz, a Stanford undergraduate, funded by Chappell-Lougee Fellowship

2001-2007 “Diversity in Medical Education”, funded by the University of California, Office

of the President 2004-2008 Roche Pharmaceuticals, A Prospective, Multicenter, Open-Label, Comparative,

Efficacy Study of Pegasys plus Copegus in Treatment of Native Latino Patients with Chronic Hepatitis C-Genotype 1, as Compared to Treatment of Native Non-Latino Caucasian Patients with Chronic Hepatitis C-Genotype 1.

2005 – 2007 The Health Trust, “Patient Advocacy Program” SOCIETIES 1987-present Member, American Gastroenterology Association 1987-1995 Member, American Federation for Clinical Research 1987-present Member, American Association for the Study of Liver Diseases 1987-present Member, American Liver Foundation 1989-present Member and Fellow, American College of Gastroenterology 1990-present Member, Board of Directors, Northern California Society for Clinical

Gastronenterology 1991-1995 Member, Crohn’s and Colitis Foundation 1992-1994 Governor (Northern California Region)

American College of Gastroenterology 1998-present Honorary Member, Associacion Argentina para el Estudio de las Enfermedades

del Higado (AAEEH)

COMMITTEES 1985-1989 Member, Panel of Examiners, Self-Study, Self-Assessment Program, Stanford

University School of Medicine and Scientific American Medicine 1987-1989 Chairman, Medical Advisory Committee and Member, Board of Directors,

American Liver Foundation, Houston Chapter, Houston, Texas 1989-1993 Gastroenterology Division Community Advisory Board, Stanford University

School of Medicine 1989-1995 Medical Specialties Clinics Steering Committee, Stanford University School of

Medicine

6


1989 Committee on Resident Training and Clinical Service, Subcommittee on

subspecialties/electives, Stanford University School of Medicine 1990-1993 Co-Chairman, Clinical Program Development Committee, Department of

Medicine 1991 Transplant Task Force, Stanford University Hospital 1991-1993 Member, Internal Medicine Residency Review Committee, Stanford University

School Member, Planning Committee, Northern California Regional Meeting, American of Medicine

1991-present Member, Residency Selection Committee, Stanford University School of

Medicine 1991-1993 Member, Educational Affairs Committee, American College of Gastroenterology 1992-1994 Member, Board of Directors, Faculty Practice Program, Stanford University

Clinic 1992-1994 Member, AGA Task Force on Minority Participation 1994-1997 Senator-At-Large, Medical School Faculty Senate, Stanford University School of

Medicine 1994-1997 Member, Program Evaluation Committee, American Association for the Study of

Liver Diseases 1994-1997 Member, Research Committee American College of Gastroenterology 1994-1997 Member, Committee on Underrepresented Minorities, American College of

Gastroenterology 1995-1999 Member, Council on Diversity, Stanford University School of Medicine 1997-1999 Member, Oversight Committee, Office of Continuing Medical Education,

Stanford University School of Medicine 1998-present Member/Director, Committee on Admissions, Stanford University School of

Medicine 1998-present Member, Committee on Admissions, Consortium of 13 Schools 1998-present Member, Faculty Advisory Board, Haas Center for Public Service, Stanford

University 1998-present Ex officio Member, School of Medicine Faculty Senate Committee of 5, Stanford

University School of Medicine

7


1999-present Member, Financial Aid Advisory Committee, Stanford University School of Medicine

2000-2002 Member, Committee on Academic Policies and Procedures, Stanford University

School of Medicine 2000-present Ex Officio Member, Committee on Student Performance, Stanford University

School of Medicine 2000-present Member, University of California Task Force on Diversity in Medical Education 2000-2003 Chair, Committee on Admissions, Consortium of 13 Schools 2001 Member, Community-Based Research Institute Advisory Committee, Haas

Center for Public Service, Stanford University 2001-present Member, Arbor Clinic Advisory Board, Stanford University School of Medicine 2001-present Member, GCRC Advisory Committee, Stanford University School of Medicine 2001-2005 Member, Committee on Admissions, Group on Student Affairs, AAMC 2001-2002 Chair, AAMC Western Group on Student Affairs 2002-2003 Member, Advisory Board, Roche Foundation 2002-present Member, Physician Relations Committee, Blue Cross of California 2004-2007 Member, Committee on Underrepresented Minorities, American

Gastroenterological Association 2004-present Member, Community Health Working Group, Haas Center at Stanford

University 2004-present LCME Task Force, Member and Subcommittee of Admissions Chair, Stanford

University School of Medicine 2004-present AAMC Diversity in Medicine Working Group 2005-2008 Senator, Faculty Senate Committee, Stanford University School of Medicine 2005-2008 Member, Consumer Relations Committee, Blue Cross of California 2006-2008 Chair, Consumer Relations Committee, Blue Cross of California 2005-2006 Member, Medical College Admissions Test Program Advisory Committee,

Association of American Medical Colleges 2006 – present Member, The Research Universities Community Engagement Network (TRUCEN), Campus Compact

8


HOSPITAL AFFILIATIONS Stanford Health Services – Active 300 Pasteur Drive Stanford, CA 94305 COMMUNITY ORGANIZATIONS Former member, Board of Trustees, Hidden Villa, Los Altos, CA REVIEWER 1990-present American Journal of Gastroenterology 1991-present Hepatology 1991-present Journal of the American Medical Association 1993-1994 Digestive Diseases and Sciences 1994-present Gastroenterology 1994-present Annals of Internal Medicine 1999-present Journal of Pediatrics 2005 Liver International PUBLICATIONS JOURNAL ARTICLES Weissberg J, Andres L, Smith C, Weick S, Nichols J, Garcia G, Robinson W, Merigan T and Gregory PB. Survival in Chronic Hepatitis B: Analysis of 379 Patients. Annals of Internal Medicine 101: 613-616, 1984. Garcia G, Scullard G, Smith C, Weissberg J, Alexander S, Gregory PB and Merigan T. Treatment of hepatitis B associated membranous glomerulonephritis with human leukocyte interferon: Report of 2 cases. Hepatology 5:317-320, 1985. Robinson WS and Garcia G. Interferon and hepatitis B. Hepatology 5:336-337, 1985. Garcia G. Non-A, non-B hepatitis. Western Journal of Medicine 143:93-94, 1985. Eisenberg M, Rosno S, Garcia G, Gregory PB, Robinson WS and Merigan TC. Preliminary trial of recombinant fibroblast interferon (Betaser) in chronic hepatitis B virus infection. Antimicrobial Agents and Chemotherapeutics 29: 122-126, 1986.

9


Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H and Robinson WS. Two observations of hepatocellular carcinoma in ground squirrels persistenly infected with ground squirrel hepatitis virus. Proceedings of the National Academy of Science 83:4543-4546, 1986. Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bisett J, Nair PV, Mastre B, Rosno S, Roskamp D, Waterman K, Pollard RB, Tong MJ, Brown BW, Robinson WS, Gregory PB and Merigan TC. Adenine arabinoside (vidarabine phosphate) monophosphate in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized, double-blinded, placebo-controlled trial. Annals of Internal Medicine 107:278-285, 1987. Garcia G and Hollinger FB, Hepatology Elsewhere: hepatitis B virus infection and renal transplantation. Hepatology 8:1172-4, 1988. Alpert E, Garcia G, Klish W and Whisennand HH. Liver transplantation: a therapeutic option in end-stage liver disease. Texas Medicine 84:68-72, 1988. Garcia G and Gentry KR. Chronic Viral Hepatitis. Medical Clinics of North America 73:971-983,1989. Garcia G, Smedile A, Bergman KF, Gerin JL, Gregory PB, Merigan TC and Robinson WS. Acute delta hepatitis during the treatment with Ara-AMP leading to resolution of HbsAg carrier state: a detailed clinical and virologic study. Western Journal of Medicine, 153: 80-82, 1990. Garcia G and Young HS. Biliary Extracorporeal Shock-Wave Lithotripsy. Gastroenterology Clinics of North America 20:201-208, 1991. Weinman D, Stewart MI, Woodley DT and Garcia G. Epidermolysis bullosa acquisita (EBA) and esophageal webs; a new association. The American Journal of Gastroenterology 86:1518-1522, 1991. Hsu HH, Wright TL, Luba D, Martin M, Feinstone SM, Garcia G and Greenberg HB. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology 1991; 14: 763-7. Kearns PJ, Young H, Garcia G, Blaschke T, O’Hanlon G, Rinki M, Sucher K and Gregory PB. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992;102:200-205. Mohle-BoetaniJ, Akula SK, Holodnyi M, Katzenstein D and Garcia G. The sulfonr syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. Western Journal of Medicine 1992;156:303-306. Ladenheim J, Yao F, Luba D, Gregory PB, Jeffrey RB and Garcia G. Limitations of liver surface ultrasound in the diagnosis of cirrhosis. Radiology 1992;185:21-24. Garcia G. Clinical features and natural history of hepatitis C. Liver Update 1992;6:3-4. Wishingrad M, Paaso B, Garcia G. Fatty Liver due to heterozygous hypobetalipoproteinemia. The American Journal of Gastroenterology 1994;89:1106-7.

10


Kuo PC, Li K, Alfrey EJ, Jeffrey RC, Garcia G, Dafoe DC. Magnetic Resonance Imaging and Hepatic Hemodynamics: Correlation with Metabolic Function in Liver Transplant Candidates. Surgery 1995;117(4):373-9. Ladenheim J, Garcia G, Titzer D, Herzenberg H, Lavori P, Edson R, Omary MD. Effect of Sulindac on Sporadic Colonic Polyps. Gastroenterology 1995;108:1083-87. Garcia G, Terrault N, Wright TL. Hepatitis C Virus Infection in the Immunocompromised Patient. Seminars in Gastrointestinal Disease 1995;6:35-45. Kuo PC, Alfrey EJ, Li K, Vagelos R, Valantine H, Garcia G, Dafoe DC. A Magnetic Resonance Imaging-Derived Parameter of Portal Flow Predicts Volume-Mediated Pulmonary Hypertension in Liver Transplant Candidates. Surgery 1995;118(4):685-91. Kuo PC, Schroeder R, Vagelos R, Valantine H, Garcia G, Alfrey E, Haddow G, Dafoe DC. Volume-mediated pulmonary responses in liver transplant candidates. Clinical Transplantation 1996;10:521-527. Chiu A, Neff M, Garcia G. Late complications of infection with Opithorchis viverrini. Western Journal of Medicine 1996;164:174-176. Hyashi M, Keeffe EB, Krams SM, Martinez OM, Ojogho OK, SO SK, Garcia G, Imperial JI, Esquivel CO. Allograft rejection after liver transplantation in patients with autoimmune liver disease. Liver Transpl Surg 1998;4:208-214. Esquivel CO, Keeffe EB, Garcia G, Imperial JC, Millan MT, Monge H and So SK. Resection versus transplantation for hepatitis B cirrhosis. Journal of Gastroenterology and Hepatology, 199914:S37-S41. So SK, Esquivel CO, Imperial JC, Garcia G, Millan MT, Monge H, Keeffe EB. Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis. Journal of Gastroenterology and Hepatology, 1999;14:S48-S52. Garcia G and Petrovic L. Overview of Hepatitis B and Transplantation in the Hepatitis B Patient. Seminars in Liver Disease, 2000:20 (1): 3-6. Fried M, Shiffman ML, Sterling RK, Weinstein J, Crippin J, Garcia G, Wright T, Conjeevaram HS, Reddy KR, Peter J, Cotsonis GA and Nolte FS. A Multi-center, Randomized Controlled Trial of Daily High Dose Interferon alfa-2b for the Treatment of Chronic Hepatitis C; pretreatment stratification by viral load and genotype. American Journal of Gastroenterology 2000;95: 3225-9

Garcia G, Keeffe EB. Liver biopsy in chronic hepatitis C: routine or selective (Editorial). American Journal of Gastroenterology 2001;96:3053-5. Nguyen MH, Garcia G. Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers. American Journal of Gastroenterology 2002;976:1092-3. Dickens T, Shiffman ML, Sterling RK, Bruno CJ, Weinstein J, Crippin JS, Garcia G, Wright TL, Conjeevaram H, Reddy RK, Nolte FS and Fried MW. Intensive Interferon Therapy Does not Increase Virologic Response Rates In Africans Americans with Chronic Hepatitis C. Digestive Diseases and Sciences 2003;48:140-5.

11


Cardenas C, Soetikno R, Friedland S, Kwan J, Robinson WS, Merigan TC, Gregory PB, and Garcia G. Long-term follow-up of patients with chronic hepatitis B: a 25-year prospective study. (submitted for publication) Simpson ND, Simpson PW, Nguyen MH, Garcia G, Keeffe EK, Ahmed A. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine: a case series. J Clin Gastroenterology 2003. Garcia G. Diversity in Medical Education Way Beyond Race. The Advisor - The Journal of the National Association of Advisors for the Health Professions, Vol. 24, No. 3, September 2004. CHAPTERS IN BOOKS Garcia G and Merigan T. Treatment of Chronic Hepatitis B. In Chisari F, editor, Advances of Hepatitis Research, Masson Publishing Company, USA, Inc., New York, 1984. Deresinki S, and Garcia G. Traveler’s Diarrhea: Major Etiologic Agents. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G. Conditions and Foods Associated with Excessive Flatulence. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G. Dysphagia: Esophageal, Oropharyngeal, and Neurologic Causes. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G. Hepatitic Failure: Causes of Fulminant Hepatitic Failure. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G. Nausea and Vomiting: Common Causes and Associate Disorders. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill, Livingstone, New York, 1990. Garcia G. Pancreatitis. In Louis AA, editor, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G and Gray G. Malabsorption and Maldigestion: Diseases Causing Malabsorption and Maldigestion . In Louis AA, Handbook of Difficult Diagnosis, Churchill Livingstone, New York, 1990. Garcia G and Luba D. Hepatitic Emergencies. In Geheb, MA and Carlson, RW editors, Principles and Practice of Medical Intensive Care, W.B. Saunders Company, Philadelphia, 1992. Garcia G. Gastrointestinal Disorders. In Melmon KL, and Morreli HF. Clinical Pharmacology: Basic Principles in Therapeutics, Third Edition, McGraw-Hill Publishing Company, New York, 1992. Garcia G. Treatment of Hepatitic Disorders and Influence of Liver Function on Drug Disposition, In Melmon KL and Morrelli HF. Clinical Pharmacology: Principles in Therapeutics, Third Edition, McGraw-Hill Publishing Company, New York, 1992.

12


Garcia G and Luba D. Hepatitic Emergencies. In Geheb MA and Carlson RW. Principles and Practice of Medical Intensive Care, WB Saunders Company, Philadelphia, 1993. Garcia G and Ladenheim J, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors, Infections of the Gastrointestinal Tract, Raven Press, New York, 1994. Garcia G and Keeffe EB. Acute Liver Failure. In LS Friedman and EB Keeffe, editors. Handbook of Liver Disease. London, Churchill Livingstone, 1998. Cusato KA and Garcia G. Hepatic Granulomas.In LJ Brandt, editor. Clinical practice of Gastroenterology. Philadelphia, Current Medicine, 1999. Cotrim HP and Garcia G. Management of Chronic Hepatitis B. In Krawitt EK, ed. Medical Management of Liver Disease, Marcel Dekker, New York, 1999. Garcia G. Gastrointestinal Disorders. In Melmon KL and Morrelli HF, Clinical Pharmacology: Basic Principles in Therapeutics, Fourth Edition, McGraw-Hill Publishing Company, New York, 2000. Garcia G. Treatment of Hepatic Disorders and the Influence of Liver Function on Drug Disposition. In Melmon KL and Morrelli HF, Clinical Pharmacology: Basic Principles in Therapeutics, Fourth Edition, McGraw-Hill Publishing Company, New York, 2000. Garcia G and Ladenheim J. Diverticulitis. In Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors, Infections of the Gastrointestinal Tract, Raven Press, New York, 2001. Garcia G. Fulminant hepatic failure. In: BF Scharschmidt, ed. In PocketMedicine/Internal Medicine. Philadelphia: PocketMedicine.com. 2003

Garcia G. Hepatorenal syndrome. In: BF Scharschmidt, ed. In PocketMedicine/Internal Medicine. Philadelphia: PocketMedicine.com. 2003 Garcia G and Keeffe EB. Acute Liver Failure. In LS Friedman and EB Keeffe, editors. Handbook of Liver Disease. London, Churchill Livingston, 2003 Parker N, Nation C, and Garcia G. Increasing Diversity in the Health Professions: A Look at Best Practices in Admission. In Bristow L, et al, In the Nation’s Compelling Interest, Insuring Diversity in the Health Care Workforce. National Academy of Science Press, 2004 Garcia G and Keeffe EB. Acute Liver Failure. In LS Friedman and EB Keeffe, editors. Handbook of Liver Disease, Second Edition. Churchill Livingstone, 2004 ABSTRACTS Young HS, Kearns P, O’Hanlon G, Rinki M, Garcia G, Blaschke T, Gregory PB. Enteral alimentation in alcoholic liver disease. Clinical Research 34:33A, 1986. Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Klein K, Cavaretto-Jordan J, Mastre B, Rosno S, Roskamp D, Co R, Waterman K, Reeves AK, Pollard RB, Tong MJ, Brown

13


BW, Robinson WS, Gregory PB, and Merigan TC. Adenine arabinoside monophosphate in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized, double-blind, placebo-controlled trial. Gastroenterology 990:1728, 1986. Garcia G and Gregory PB. Routine liver tests in chronic hepatitis B: correlation with findings on liver biopsy. Clinical Research 36:131, 1988. Garcia G, Gregory PB, Merigan TC, and Robinson WS. Chronic delta hepatitis virus infection: prevalence in a hepatology referral center and prognosis: Clinical Research 36:131, 1988. Hsu HH, Wright Tl, Luba D, Garcia G, Greenberg HB. Is Hepatitis C virus in human secretions? Gastroenterology 100:A754, 1991. Garcia G, Luba D, Gregory PB, Jeffrey RB. Limitations of liver surface ultrasound in the diagnosis of cirrhosis. The American Journal of Gastroenterology 86:1327, 1991. Luba D, Hsu H, Martin MC, Gregory PB, Greenberg HB, Garcia G. Failure of Transmission of Hepatitis C Through Household or Sexual Contact. Hepatology 1991;14:77A. O’Brien CB, Henzel B, Long WB, Garcia G, Strayer D, Hubbell H and Carter W. A Phase I/II Study of Ampligen (Poly I:Poly C12U) for the Treatment of Chronic Hepatitis B (HBV). Hepatology 18:247A, 1993. Yao F, Ladenheim J, Martin MC, Gregory PB, Garcia G. Natural History of chronic hepatitis C: baseline characteristics and correlation between laboratory tests and liver biopsy findings. Gastroenterology, 1993;104(4:2):A1021. Ladenheim J, Yao F, Martin MC, Gregory PB, Mangels C, Garcia G, Survival in Chronic Hepatitis B: A 15-year Follow-up. Hepatology 18:119A, 1993. Wishingrad M, Paaso B, Garcia G. A Rare Metabolic Cause of Fatty Liver. The American Journal of Gastroenterology 88:1634,1993. Warford A, Garcia G, Wolfe L, Yoder A, Mathie S, Merigan T. Evaluation of the Roche Hepatitis C Virus RNA Ploymerase Chain Reaction Assay. ASM C372(556), 1994. O’Brien CB, Garcia G, Henzel B, Martin M, Ladenheim J, Ginsberg G, Hubbell H, Strayer D, Carter W. Ampligen Treatment of Chronic Hepatitis B. Gastroenterology 106:A952, 1994. Ladenheim J, Garcia G, Titzer D, Herzenberg H, Lavori P, Edson R, Omary MB. Effect of Sulindac on Sporadic Colonic Polyps. Gastroenterology 106:A407, 1994. Kuo PC, Alfrey EJ, Garcia G, Haddow G, Dafoe DC. Orthotopic Liver Transplantation with Selective Use of Venoveno-Bypass. The American Journal of Surgery, 1995. So SKS, Esquivel CO, Imperial JC, Garcia G, Concepcion W, Keefe EB. Liver Transplantation for HBeAg-positive chronic HBV cirrhosis. (submitted) So SKS, Esquivel CO, Imperial JC, Garcia G, Monge T, Concepcion W, Ojogho O, Esquivel CO. Neither Asian race or presence of HbeAg affect survival or HBV recurrence after liver transplantation for HBV cirrhosis. (Submitted)

14


Samina Taha, Byron W, Gabriel Garcia. Susceptibility to and resolution of hepatitis B: HLA is NOT a factor. Gastroenterology 1997;5:A534. Garcia G, Cardenas C, Soetikno R, Friedland S, Robinson WS, Merigan TC, and Gregory PB. Long-term follow-up patients with cirrhosis due to chronic hepatitis B: a 25 year prospective study. American Journal of Gastroenterology 1999; 94:182A. (Awarded the American College of Gastroenterology Governor’s Award for Excellence in Research). Cardenas C, Soetikno R, Friedland S, Kwan J, Robinson WS, Merigan TC, Gregory PB, and Garcia G. Long-term follow-up of patients with chronic hepatitis B: a 25-year prospective study. Hepatology 1999; 39:300A. Iturbe JM, Kushida C and Garcia G. Sleep and Cirrhosis. Sleep 2005;28;152A CORRESPONDENCE Garcia G, Robinson WS, Gregory PB, and Merigan TC. Hepatitis B associated membranous glomerulonephritis treated with adenine arabinoside monophosphate. Hepatology 6:763, 1986. OTHER Nierenberg D, Garcia G, Raffin T, and Perlroth M. House-Staff Procedure Manual. Stanford University, Department of Medicine, 1981. Garcia G, guest editor. Annual Review of Medicine: Selected Topics in the Clinical Sciences, Volume 44. Annual Reviews Inc, Palo Alto, CA 1993. MAJOR EDUCATIONAL ACTIVITIES Meeting Chair and Organizer, Joint AAMC Western Group on Student Affairs and Western Association of Advisors to the Health Professions Meeting, Asilomar, Ca, April 22-25, 2001 Faculty Advisor, Alternative Spring Break, Health Care for Marginalized Communities, Winter 2001 and 2002 Course Director, Med 101 – The Human Side of Medicine. 3 units, Winter 2001, 2002, 2003, 2004 Course Director, Med 257a-c – Patient Advocacy Course, Fall and Winder 2004, Spring 2005 Program Director, Diversity in Medical Education, US Uniformed Health Services Board of Regents Retreat, Stanford, CA, January 30, 2004 Key Informant, Sullivan Commission on Diversity in Medical Education, Stanford, CA, February 17, 2004

15


INVITED SPEAKER 1983 Medical Grand Rounds, Stanford University School of Medicine. Hepatitis B in

Pregnancy – Diagnosis and Management

Medical ICU Grand Rounds, Stanford University School of Medicine. Immune Deficiency Syndrome – Update on Communicability

Lecture Series, Southern California Society of Gastroenterology. Antiviral and Immunosuppressive Therapy in Chronic Hepatitis B

1985 Medical ICU Grand Rounds, Stanford University School of Medicine. Fulminant

Hepatic Failure

Morbidity and Mortality Conference, Department of Medicine, Stanford University School of Medicine, Evaluation of Gastrointestinal Bleeding, 1985.

1986 Instructor, Preparation for Clinical Medicine Course, Stanford University School of Medicine

Office of Postgraduate Education Review Course in Intensive Care

Medical Grand Rounds, Department of Medicine, Stanford University School of Medicine, Hepatic Coma

Medical Grand Rounds, Department of Medicine, Stanford University School of

Medicine. Fulminant Hepatic Failure 1988 Medical Grand Rounds, Department of Medicine, Stanford University School of

Medicine, Liver Transplant

Course Director and Speaker, A Clinical Update in Gastronenterology, Baylor College of Medicine, Treatment of Chronic Hepatitis, November 30, 1988

1989 House Staff Noon Lectures, Department of Medicine, Stanford University School

of Medicine. Diagnosis and Treatment of Chronic Viral Hepatitis

House Staff Noon Lectures, Department of Medicine, Stanford University School of Medicine. Therapy of Fulminant Hepatic Failure

UCLA Extension Course, Newport, Beach, CA. Advance in the Treatment of Hepatitis

Medical Grand Rounds, San Mateo County Medical Center, San Mateo, CA. Treatment of Viral Hepatitis

Physicians Assistant Students Lecture, Stanford University School of Medicine. Viral hepatitis

16


1990 Session Chairman and speaker, Sino-American Scientific Symposium of Ribavirin: A Broad Spectrum Antiviral Agent. Viral Hepatitis, Beijing, People’s Republic of China, January 15-17, 1990

Liver Symposium, Pacific Presbyterian Medical Center, Old and New Treatments for Viral Hepatitis, January 20, 1990 Physician’s Assistant Student Lecture, Stanford University School of Medicine. Cirrhosis, March 26, 1990

Advances in Biliary Lithotripsy Course, Stanford University School of Medicine. Medical Therapy of Gallstones, April 22, 1990

Medical Grand Rounds, The Permanente Medical Center, Oakland, CA. Evaluation of chronically abnormal liver function tests, June 12, 1990.

House Staff Noon Lectures, Department of Medicine, Palo Alto VAMC. Therapy of Fulminant Hepatic Failure, September 10, 1990

Medical Grand Rounds, San Mateo County Medical Center, San Mateo, CA. Evaluation of chronically abnormal liver functions tests, September 13, 1990 Medical Grand Rounds, Watsonville Community Hospital, Watsonville, CA. Evaluation of chronically abnormal liver function tests, October 22, 1990

Medical Microbiology 202, Stanford University School of Medicine. Viral Hepatitis, November 13, 1990

Physician’s Assistant Student Lecture, Stanford University School of Medicine. Gastrointestinal Bleeding, November 15, 1990

Course Director and Speaker, Symposium on Advances in the Treatment of Viral Hepatitis, Stanford University School of Medicine, December 15, 1990

1991 Invited speaker, Chronic Viral Hepatitis C, D, E and Gastrointestinal

Manifestations of AIDS, Asociacion de Medicina Interna de Guatemala, IX Congreso Anual de Medicina Interna, Guatemala City, Guatemala, January 3-February 2, 1991

Medicine House Staff Board Review Course, Stanford University School of Medicine. Liver Diseases and GI Manifestations of AIDS, March 11, 1991

Medical Staff Conference, Washington Township Hospital, Diagnosis and Treatment of Viral Hepatitis, March 12, 1991 Medical Staff Conference, Good Samaritan Hospital, Diagnosis and Treatment of Viral Hepatitis, March 21, 1991 Physician’s Assistant Student Lecture, Stanford University School of Medicine. Cirrhosis, March 28, 1991

17


Internal Medicine Grand Rounds, San Mateo County General Hospital. Common Complications of Cirrhosis, March 28, 1991 American College of Physician’s Meeting, Flexible Sigmoidoscopy, April 12, 1991

Medical Staff Conference, O’Connor Hospital, Diagnosis and Treatment of Viral Hepatitis, May 28, 1991

Medical Staff Conference, Kaiser Redwood City, Diagnosis and Treatment of Viral Hepatitis, May 31, 1991

Medical Staff Conference, Kaiser Santa Teresa, Diagnosis and Treatment of Viral Hepatitis, June 5, 1991

Course Director and Speaker, Symposium on Advances in the Treatment of Acid-Peptic Disorders, Stanford University School of Medicine, June 29, 1991 House Staff Noon Lectures, Department of Medicine, Stanford University School of Medicine. Diagnosis and Treatment of Chronic Viral Hepatitis, August 19, 1991

Medical Staff Conference, Alexian Brothers Hospital, Diagnosis and Treatment of Viral Hepatitis, August 27, 1991

Physician’s Assistant Student Lecture, Stanford University School of Medicine. Viral Hepatitis/Upper and Lower GI Bleeding, October 24, 1991

XIV Congreso de Gastroenterologia de Centroamerica y Panama, Guatemala City, Guatemala, Ejercicio extenuante y fallo hepatico, Higado Y Androgenos, Interferon – Hepatitis B y D, Transplante de Higado, Fallo Hepatico, November 14-16, 1991

General Surgery Grand Rounds, Stanford University School of Medicine, Primary Sclerosing Cholangitis, December 14, 1991

1992 Stanford Pediatric Gastroenterology Clinic Conference, Update on Hepatitis C,

January 9, 1992

Aptos Primary Care Medicine Society, Diagnosis and Management of Viral Hepatitis C, January 28, 1992

Pediatric Liver Transplantation Symposium, Stanford University School of Medicine, Anatomy, Physiology and Indications for Liver Transplantation, February 4 an 19, 1992

Staff Inservice Conference, Multi-organ Transplant Unit, Viral Hepatitis, February 25 and 27, 1992 Pathophysiology Course, Stanford University School of Medicine, Liver Function and Failure, March 2, 1992

18


Medical Staff Grand Rounds, Community Hospital of the Monterey Peninsula, Evaluation and Management of Chronic Hepatitis, March 25, 1992 American College of Physicians Annual Meeting, Flexible Sigmoidoscopy, March 27, 1992 Lecture Coordinator for Gastroenterology Section and Lecturer, Liver and Biliary Tract Disease Preparation for Clinical Medicine, Stanford University School of Medicine, May 6-8, 1992 Stanford/UCSF GI Research Symposium, Hepatitis C: Natural History Studies, San Francisco, November 14, 1992

1993 House Staff Noon Lectures, Department of Medicine, Stanford University School of Medicine, Evaluation of Chronic Hepatitis, February 19 and 26, 1993

American College of Gastroenterology Regional Postgraduate Course, Update on Chronic Hepatitis and Liver Transplantation, March 20, 1993 American College of Physicians Annual Meeting, Flexible Sigmoidoscopy, April 3, 1993 American Liver Foundation Public Education Program, Transmission of Hepatitis B and C, May 13, 1993 Stanford University Hospital Nursing Staff Education, Indications for Orthotopic Liver Transplantation, May 24, 1993 Roseville Hospital Medical Staff, Update on Viral Hepatitis, September 24, 1993

1994 The United Liver Association/Northern California Chapter, Current Advances in Hepatitis, January 22, 1994

San Jose Peninsula District of the California Dietetic Association and the American Dietetic Association Foundation, How Does One Nourish Patients with Liver Disease?, March 5, 1994 ICU Fellowship Lecture Series, Liver Failure, April 14, 1994 Primary Care Program, Viral Hepatitis, April 27, 1994

Physician’s Assistant Program, Liver Diseases Producing Cirrhosis, May 2, 1994 Primer Congreso Nacional de Gastroenterologia Hepatologia Y Endoscopia Gastrointestinal, Guatemala, Centroamerica, Hepatitis Viral Tipo C, Transplante Hepatico Y TIPS, Vacunas Contra la Hepatitis Viral, May 21, 1994 Cowell Student Health Service, Hepatitis C, June 8, 1994

19


Stanford Nursing Education Workshops, End Stage Liver Disease, June 20 and 27, 1994 The Cypress Foundation, Chronic Hepatitis and Management of Cirrhotic Ascites, September 23, 1994 American Liver Foundation, Viral Hepatitis: Strategies for Prevention, October 29, 1994 Washington Hospital, Chronic Hepatitis: An Update, December 9, 1994

1995 Santa Clara Medical Society, Evaluation of Abnormal Liver Function Tests, April 18, 1995

Primary Care Associate Program, Cirrhosis, May 1, 1995 Santa Cruz Medical Group, Hepatitis B and C, June 26, 1995 California Pacific Medical Center: Liver Update, Hepatic Encephalopathy: New and Old Therapies, July 22, 1995 Highland Hospital Medical Staff, The Management of Ascites, July 28, 1995 International Convention of the Vietnamese Physicians of the Free World, Hepatitis A-E and Beyond, July 30, 1995 Alexian Brothers Hospital Medical Staff, Hemochromatosis, September 25, 1995

Mills Hospital Medical Staff, Diagnosis and Management of Chronic Viral Hepatitis, September 27, 1995 Primary Care Associate Program, Viral Hepatitis, October 26, 1995 Kaiser Oakland Internal Medicine Staff, Controversies in Hepatitis C, November 7, 1995 San Jose Medical Center Staff, Hepatitis B, November 9, 1995 San Mateo County Pharmacists Association, Viral Hepatitis, November 16, 1995 Fresno Gut Club, Treatment Modalities for Hepatitis B and C, November 28, 1995

1996 Washington Hospital Medical Staff, Hepatitis B, January 12, 1996

Milwaukee Medical Society, Update on Viral Hepatitis, February 14, 1996 Stanford University Division of Nephrology Clinical Conference, Treatment of Hepatitis C in Renal Disease, February 22, 1996

20


Enloe Hospital, Medical Staff Conference, Treatment of Chronic Viral Hepatitis, February 29, 1996

International Transplant Nurses Society, Northern California Chapter, Hepatitis C, March 4, 1996 ICU Fellowship Lecture Series, SUMC Liver Failure, March 14, 1996 San Mateo General Hospital, Evaluation of Abnormal Liver Function Tests, May 23, 1996 Asociacion Guatemateca de Gastroenterologia, Hepatologia y Endoscopia Gastrointestinal, Segundo Congreso Nacional de Gastroenterologia, Hepatologia y Endoscopia Gastrointestinal,Hepatitis a-G, Hepatocellular Carcinoma: Problems of Diagnosis and Management, Hepatitis C: Treatment and Modalities, Liver Transplantation, July 26, 1996 Medical Staff, O’Connor Hospital, Update on Viral Hepatitis C, August 6, 1996 Alaska Regional Hospital, Viral Hepatitis and Liver Disease Update, Hepatitis A-C, Hepatocellular Carcinoma, Cirrhotic Ascites, October 24, 1996 Department of Medicine Core Curriculum, SUMC, Liver Failure, October 15, 1996 Physician’s Assistant Program, SUMC, Viral Hepatitis, October 24, 1996 Medical Staff, Enloe Hospital, Ascites in patients with cirrhosis: What to do. November 14, 1996 Asociacion Costarricense de Medicina Interna, Hepatitis Viral Aguda and Transplante de Higado, Costa Rica, Central America, December 3, 1996

1997 Stanford Critical Care Unit, Management of Acute Liver Failure, January 21, 1997

Kaiser Santa Clara Medical Staff, Diagnosis and Management of Ascites, February 4, 1997 ICU Fellowship, Fulminant Hepatic Failure, March 6, 1997 Doctor’s Medical Center, Grand Rounds: Update on Hepatitis C, March 19, 1997 Enloe Hospital, Primary Liver Cancer: An Update, April 17, 1997

Mad River Hospital, New Discoveries in Viral Hepatitis: Natural History, Treatment and Liver Cancer Surveillance, May 1, 1997 St. Joseph Hospital, New Discoveries in Viral Hepatitis: Natural History, Treatment and Liver Cancer Surveillance, May 1, 1997

21


Ukiah Valley Medical Center, Hepatitis C: The Epidemic, May 31, 1997

American Association for the Study of Liver Diseases: Natural History of Chronic Hepatitis B, June 27-28, 1997

1998 American College of Gastroenterology, Regional Postgraduate Course, Chronic

Viral Hepatitis B. Phoenix, Arizona, January 31, 1998

Visiting Professor, Universidad Federal da Bahia, Hospital Universitario Prof. Edgar Santos, Salvador, Brazil, March 19-21, 1998 Argentine Association for the Study of Liver Diseases, Natural History of Hepatitis B, March 1998 American Liver Foundation, National Single Topic Conference, Natural History of Chronic Hepatitis B, June 11-13, 1998 Visiting Professor, Inyo County Medical Society, July 23-24, 1998 Biology Scholars Program, University of California at Berkeley, A Career in Medicine. Berkeley, CA, September 2, 1998 Visiting Professor, Intermountain Health Services, Chronic Viral Hepatitis, Salt Lake City, UT, October 25, 1998 AIDS Clinical Research Consortium Community HIV Forum, The Patient with HCV and HIV co-infection. Palo Alto, CA, November 11, 1998 Medical Grand Rounds, Highland Hospital, Management of Endstage Liver Disease. Oakland, CA December 18, 1998

1999 CUHRE Alumni Meeting, Humanism in Medicine, San Diego, CA January 23, 1999

Medical Staff Conference, Community Hospital of the Monterey Peninsula, Update in Chronic Viral Hepatitis. Carmel, CA, January 27, 1999 American College of Gastroenterology, Regional Postgraduate Course, Chronic Viral Hepatitis. Napa, CA, February 13, 1999 Medical Staff Conference, St. Louis Medical Center, Management of Chronic Viral Hepatitis. Gilroy, CA, March 9, 1999

Visiting Professor, Universidad Federal da Bahia, Hospital Universitario Prof. Edgar Santos, Salvador, Brazil, May 25-28, 1999 Mills College, Hepatitis C and HIV, Oakland, CA, June 10-11, 1999 Marysville Yuba City GI Society, Update on Hepatology. Marysville, CA August 26, 1999

22


National Association of Minority Medical Educators, An Admissions Officers Perspective on Multiculturalism, Dallas, Texas, September 20, 1999

American College of Gastronenterology, 1999 Annual Postgraduate Course, Alcoholic Liver Disease and Work-up of Hepatic Masses. Phoenix, Arizona, October 17, 1999

University of Pennsylvania Premed Society, Finding Meaning in a Career in Medicine, Philadelphia, PA, October 25, 1999

Invited Speaker, Regional meeting, Chicanos in Health Education, Stanford University, November 13, 1999

2000 University of Chicago: Preparing for a Career in Medicine; the value of a liberal arts education, January 15, 2000.

UC Davis, Applying to Medical School. February 4, 2000.

Undergraduate Advising Center at Stanford University, Applying to Medical School. February 8, 2000.

Human Biology Program at Stanford University, A Career in Medicine. February 8, 2000.

Stanford University Minority Medical Association, Applying to Medical School. February 19, 2000

MIT Advising Center, A Career in Medicine, February 22, 2000

Harvard College Advising Center, Why Stanford for Medical School, February 22, 2000.

Brown University, Why Stanford for Medical School, February 23, 2000.

University of Utah, Why Stanford for Medical School, March 20, 2000.

Eastside High School Sophomores, Why Medicine, March 28, 2000. Consortium of 13 Schools Meeting, Affirmative Action in Medical School Admissions, April 15, 2000.

Cornell University, Why Stanford for Medical School, April 17, 2000.

Career Night for Stanford Students, Why a Career in Internal Medicine, April 18, 2000.

Chicanos for Health Education, A Career in Medicine, May 16, 2000.

23


Stanford Medical Youth Science Program, A Career in Medicine, June 27, 2000.

National Association of Advisors in the Health Professions Annual Meeting, Applying to Medical School. June 30, 2000

Stanford Medical Youth Science Program, A Career in Medicine, July 7, 2000.

Stanford Health Career Opportunity Program, A Career in Medicine, July 28, 2000.

Northwestern University, A Career in Medicine, October 26, 2000.

Freshman-Sophomore College at Stanford University, How to Plan for a Career in Medicine, November 8, 2000.

Minority Graduate Student Symposium, How to Finance a Career in Medicine, November 11, 2000.

Sterling Alumni Award Dinner, What it Takes to Get into Med School Today, November 15, 2000.

Board of Trustees, Stanford University, Report on Medical School Admissions, December 11, 2000.

UC Davis Postgraduate Course in Infectious Diseases, Update on Management of Hepatitis B and C infections, February 5, 2000.

Department of Anesthesia, Hepatic Insufficiency - Pathophysiology of Liver Failure, March 2, 2000

ACRC, HCV peer education class, March 14, 2000

Central American Society for Gastroenterology, Visiting Professor during Annual Meeting in Guatemala City, June 14-18, 2000.

GI Emergencies Course, What to do when something goes wrong, July 29, 2000

VA Conference on Management of Hepatitis C, The Role of the Liver Biopsy, August 15, 2000.

2001 Keynote Speaker, What makes a good medical student, Stanford University

Minority Medical Association Conference, February 10, 2001

Yale College Premedical Association, The Medical School Admissions Process, Yale College, February 20, 2001

24


Princeton University Premedical Advisor Conference, What makes a good medical student, Princeton University, February 21, 2001 Critical Care Clinical Conference, Hepatic Insufficiency, March 1, 2001 UC Davis Premedical Society, The Medical School Admissions Process, UC Davis, March 13, 2001

Visiting Professor and Chancellor’s Lecturer, Diversity in California Medical Schools and Needs of the Workforce, Duke University School of Medicine, March 26-28, 2001

UC Irvine Biology 3A Course Lecturer, The Medical School Admissions Process, UC Irvine, April 10, 2001

Keynote Speaker, Andrew Hill High School Graduation Ceremony, Careers in Health Care, May 24, 2001

Master Clinician, Preparation for Clinical Medicine Course, Jaundice, May 25, 2001

National Hispanic Medical Association Meeting, Career Choices in Medicine, Sacramento, CA, September 11, 2001

Invited Speaker, University of California Pre-Medical Advisory Conference, The Admissions Process, September 19-20, 2001

Invited Speaker, Primary Care Associate Program, Viral Hepatitis, Stanford University School of Medicine, September 25, 2001.

Moderator, Advances and Controversies in Clinical Hepatology, American Association for the Study of Liver Diseases Annual Meeting, November 12, 2001

Invited Speaker, Stanford University School of Medicine Alumni Association, What it Takes to Get into Medical School Today, November 15, 2001

Invited Speaker, Department of Medicine Morbidity and Mortality Conference, Fulminant Hepatic Failure, November 28, 2001

Invited Speaker, Living Now Class, Hepatitis C, AIDS Clinical Research Consortium, Redwood City, Ca, December 13, 2001

2002 Living Now Class, Hepatitis C, AIDS Clinical Research Consortium, Redwood

City, January 23, 2002

Stanford Minority Medical Alliance Conference, The Admissions Process, Stanford University, February 2, 2002

Johns Hopkins University, What Medical Schools Look For in Their Applicants, Baltimore, February 23, 2002

25


Northern California Premedical Advisors Conference, The Admissions Process, UC Berkeley, March 1, 2002

Gastroenterology and Hepatology Clinical Conference, Antiviral Therapy of Hepatitis B, April 3, 2002

Chaired and prepared summary of meeting, Committee on Admissions, Consortium of 13 Schools Meeting, Washington University School of Medicine, St. Louis, April 6-7, 2002

Princeton University, Developing Diversity in the Medical Workforce, Princeton, April 9, 2002

UC Davis, The Admissions Process, Davis, May 7, 2002

University of Santa Clara, What Medical Schools Look For in Their Applicants, Santa Clara, May 13, 2002

National Association of Advisors to the Health Professions, Developing Diversity in the Medical Workforce, Las Vegas, June 24, 2002

Stanford Medical Youth Science Program, A Career in Medicine, Stanford University, July 26, 2002

Gilead Sciences Symposium, Epidemiology and Natural History of Hepatitis B, Stanford University, August 9, 2002

American River College, What Medical Schools Look For in Their Applicants, Sacramento, September 6, 2002

Critical Care Conference, Fulminant Hepatic Failure, September 10, 2002

Southern California Premedical Advisors Conference, The Admissions Process, UC San Diego, October 12, 2002

Harvard College, What Medical Schools Look For in Their Applicants, Boston, October 21, 2002

Stanford University School of Medicine Alumni Association, What it Takes to get Into Medical School Today, Boston, October 22, 2002

Massachusetts Institute of Technology, What Medical Schools Look For in Their Applicants, Boston, October 23, 2002

Primary Care Associates Program, Viral Hepatitis, Stanford University, October 24, 2002

Living Now Class, Hepatitis C, AIDS Clinical Research Consortium, Redwood City, October 29, 2002

26


Society of Gastrointestinal Nurses and Assistants, Controversies in Hepatitis C – Use of the Liver Biopsy, Boston, November 3, 2002

Chaired and prepared summary of meeting, Committee on Admissions, Consortium of 13 Schools Meeting, Washington University School of Medicine, San Francisco, November 9, 2002

Association of American Medical Colleges National Meeting, Panel Chair and Presenter, Developing Diversity in the Medical Workforce, San Francisco, November 10, 2002

UCLA Career Center, What Medical Schools Look For in Their Applicants, Los Angeles, November 13, 2002

2003 Association of American Medical Colleges Professional Development Impact of

Debt on Career Choices in Medicine, San Diego, January 15, 2003

AAMC Financial Aid Professional Development Conference, Career Choices in Medicine: Impact of Financial Aid and Debt. San Diego, January 17, 2003

Living Now Class, Hepatitis C, AIDS Clinical Research Consortium, Redwood City, January 21, 2003

National Institutes of Health Academy, What Medical Schools Look For in Their Applicants, Washington, January 27, 2003

Stanford Minority Medical Alliance Conference, The Admissions Process, Stanford University, February 1, 2003

Institute of Medicine Committee on Diversity in the Medical Workforce, The Role of the Office of Admissions in Developing a Diverse Medical Workforce, February 5, 2003 Stanford University, What Medical Schools Look For in Their Applicants, Stanford, February 18, 2003

Living Now Class, Hepatitis C, AIDS Clinical Research Consortium, Redwood City, March 4, 2003 Critical Care Conference, Hepatic Insufficiency – Pathophysiology and Management, March 6, 2003 Critical Care Conference, Fulminant Hepatic Failure, March 6, 2003

UC Irvine, The Admissions Process, Irvine, February 12, 2003

University of Southern California, What Medical Schools Look For in Their Applicants, Los Angeles, February 12, 2003 AIDS Clinical Research Consortium, Living with Hepatitis C, Redwood City, March 4, 2003

27


UC Irvine Biology 3A, Applying to Health Professional Schools, Irvine, March 12, 2003 University of Southern California Health Careers Meeting, What Medical Schools Look for in Their Applicants, Los Angeles, March 12, 2003 Internal Medicine Morning Report, Liver Abscesses, March 14, 2003 Northern California Premedical Advisors Conference, The Admissions Process, UC Davis, March 28, 2003 Preparation for Clinical Medicine, Master Clinician Discussion, April 4, 2003 Keynote Speaker, AAMC North East Group on Student Affairs, Developing and Nurturing the Diversity of the Medical Workforce, Philadelphia, April 24-26, 2003 Planning Committee Member, Western Group on Student Affairs Annual Meeting, Asilomar, April 18-30, 2003 UC Davis, What Medical Schools Look for in Their Applicants, Davis, May 12, 2003 Society of Gastrointestinal Nurse Assistants, The Role of the Liver Biopsy in Hepatitis C, Atlanta, May 18, 2003 Early Matriculation Program Seminar, Viral Hepatitis, August 1, 2003 American River College, What Medical Schools Look for in Their Applicants, Sacramento, September 13, 2003 College of San Mateo, What Medical Schools Look for in Their Applicants, San Mateo, September 27, 2003 Dartmouth College Health Careers Meeting, What Medical Schools Look for in Their Applicants, Hanover, October 2, 2003 Cornell University Health Careers Meeting, What Medical Schools Look for in Their Applicants, Ithaca, October 7, 2003 Columbia College Health Careers Meeting, What Medical Schools Look for in Their Applicants, Hanover, October 8, 2003 Yale College Health Careers Meeting, What Medical Schools Look for in Their Applicants, Hanover, October 9, 2003 UC Irvine Premedical Career Counselors Conference, Extracurricular Activities, October 11, 2003

28


AIDS Clinical Research Consortium, Living with Hepatitis C, Redwood City, October 14, 2003 Med Micro 212 Lecture, Infections of the Liver, November 3, 2003 Moderator and Invited Speaker, AAMC Career Awareness Workshop, Getting into Medical School, November 8, 2003

Oregon State University Health Careers Meeting, What Medical Schools Look for in Their Applicants, Corvallis, November 17, 2003 Washington University Health Careers Meeting, What Medical Schools Look for in Their Applicants, Seattle, November 18, 2003

2004 Stanford University Health Careers Symposium, What Medical Schools Look for

in Their Applicants, Stanford, CA, January 20, 2004 Stanford University Minority Health Alliance, Invited Speaker at Pre-Med

Conference, What Medical Schools Look for in Their Applicants, Stanford, CA January 31, 2004

Stanford University, “Coloring the Portrait of Medicine: A Forum on the State of

Minorities in Academic Medicine.” Invited Panelist, Stanford, CA, February 5, 2004

American College of Physicians, Regional Conference Invited Speaker, Hepatitis

C, Las Vegas, NV, February 7, 2004 SCOPE, What Medical Schools Look for in Their Applicants, Stanford, CA,

February 9, 2004 Medical Housestaff Lecture, Ascites, Palo Alto VAMC, Palo Alto, CA, February

13, 2004 Medical Housestaff Lecture, Spontaneous Bacterial Peritonitis, Stanford, CA,

February 20, 2004 Co-Director, Premedical Advisors Conference, UC Task Force for Diversity in

Medical Education, Sacramento, CA, March 20, 2004 UCLA Premedical Society, What Medical Schools Look for in Their Applicants,

Los Angeles, CA, May 5, 2004 UC Davis Premedical Society, What Medical Schools Look for in Their

Applicants, Davis, CA, May 27, 2004 AAMC Professional Development Conference, Electronic Application and

Decision Tools for Medical Schools, Santa Fe, NM, June 11, 2004 National Association of Advisors to the Health Professions, Keynote Speaker,

Diversity in Medical Schools-Way Beyond Race, Washington, DC, June 28, 2004

29


Quest Students, What Medical Schools Look for in Their Applicants, Stanford,

CA, July 27, 2004 Health Careers Opportunity Program, Keynote Address, A Career in Medicine,

Stanford, CA, July 27, 2004 Chinese American Physician Society, Institute for Medical Education’s CME

Program entitled “Hot Topics in Hepatology: Updates, Strategies and Future Trends,” Chronic Hepatitis C, Napa, September 11, 2004

American River College, What Medical Schools Look for in Their Applicants,

Sacramento, CA, September 25, 2004 Harvard College, Phillips Brooks House, What Medical Schools Look for in

Their Applicants, Boston, MA, November 4, 2004 AAMC Minority Medical Career Awareness Workshop, Moderator and Speaker,

Boston, MA, November 6, 2004 American Indian Physicians Association Annual Meeting, Director and Keynote

Speaker of Premedical Conference, Stanford, CA, December 3-4, 2004 Chicano-Latino Faculty Noon Seminar, Basing Admissions Decisions on

Accomplishments, Stanford, CA, December 6, 2004 2005 Post Doc Fellows Conference, Ascites and Peritonitis, Stanford, CA, January 18,

2005 Stanford University Minority Health Alliance, Invited Speaker at Pre-Med

Conference, Welcome and Making Yourself a Better Applicant, Stanford, CA, February 5, 2005

Critical Care Conference, Acute Liver Failure – Pathophysiology and

Management, Stanford, CA, February 17, 2005

NIH, Bethesda, MD, What Medical Schools are Seeking in Their Applicants, March 20, 2005 American Association of Veterinary Medical Colleges, Iverson Bell Symposium, Diversity in Medical Schools-Way Beyond Race, Washington, DC, March 11, 2005 Cal State Humboldt, What Medical Schools are Seeking in Their Applicants, April 25, 2005 Visiting Professor, Universidad Federal de Recife, Brazil. Presentations: Management of Chronic Viral hepatitis, Combination Therapy for Chronic Hepatitis B and Evaluation and Treatment of hepatitis C. May 5-7, 2005

30


Chronic Liver Disease Foundation, New Insights Into the Management of Hepatitis C, Eureka, CA, August 1, 2005

2006

Stanford University Minority Health Alliance, Invited Speaker at Pre-Med Conference, Welcome and Making Yourself a Better Applicant, Stanford, CA, February 4, 2006 Visiting Professor, Guatemalan Society of Gastroenterology. Presentations: Hepatic Encephalopathy, Fatty Liver and Cryptogenic Cirrhosis and Evaluation and Treatment of hepatitis C. February 22-24, 2006 Critical Care Conference, Acute Liver Failure – Pathophysiology and Management, Stanford, CA, March 2, 2006

March 22, 2006

31

GABRIEL GARCIA, M - Stanford University

Documents

Transcript of GABRIEL GARCIA, M - Stanford University